Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 29, 2018 07:00 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics Announces Appointment of Ernst & Young LLP as the Company’s Independent Auditor

SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (“Arcturus” or the “Company”) (NASDAQ: ARCT), a leading RNA medicines company, today announced that at the Company’s Annual...
August 28, 2018 07:00 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer

SAN DIEGO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, today announced that it has appointed Andrew Sassine as Interim Chief...
August 27, 2018 07:00 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics to Present at Three Investor Conferences in September

SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, today announced that Joseph E. Payne will present at the upcoming...
July 23, 2018 07:00 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation Therapeutics

SAN DIEGO, July 23, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced the achievement of key milestones as part of its agreement...
July 20, 2018 17:23 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics Announces Annual and Extraordinary General Meeting of Shareholders to Be Held on August 24, 2018

SAN DIEGO, July 20, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (“Arcturus” or the “Company”) (NASDAQ:ARCT), an RNA medicines company, today announced that it will hold an Annual and...
July 09, 2018 08:30 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics Announces Results of Extraordinary General Meeting of Shareholders

All Four Proposals Approved by Shareholders SAN DIEGO, July 09, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced that at its...
June 18, 2018 04:00 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics to Present at the JMP Securities Life Sciences Conference

SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced that it plans to present at the JMP Securities Life Sciences...
May 31, 2018 07:00 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEO

Industry veteran Dr. Peter Farrell named as Chairman of the Board, Dr. Pad Chivukula reinstated as CSO and COO SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd....
May 30, 2018 22:32 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders

SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (“Arcturus” or the “Company”) (NASDAQ:ARCT), an RNA medicines company, today announced that the Extraordinary General Meeting...
May 23, 2018 21:45 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics Comments on Court Ruling on Undisclosed Group Organized by Joseph E. Payne and his Associates in Violation of Regulation 13D

California Federal Court Rules that Arcturus is Likely to Succeed on Merits of its Claims Against Payne Further Violations by Payne and His Associates Enjoined to Permit all Arcturus Shareholders to...